Publication

Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis.

Journal Paper/Review - May 11, 2022

Units
PubMed
Doi
Contact

Citation
Fischer T, El Baz Y, Graf N, Wildermuth S, Leschka S, Kleger G, Pietsch U, Frischknecht M, Scanferla G, Strahm C, Wälti S, Dietrich T, Albrich W. Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis. Diagnostics (Basel) 2022; 12
Type
Journal Paper/Review (English)
Journal
Diagnostics (Basel) 2022; 12
Publication Date
May 11, 2022
Issn Print
2075-4418
Brief description/objective

COVID-19 superinfection by Aspergillus (COVID-19-associated aspergillosis, CAPA) is increasingly observed due to increased awareness and use of corticosteroids. The aim of this study is to compare clinical and imaging features between COVID-19 patients with and without associated pulmonary aspergillosis.